U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07553182) titled 'OLE Study With Filgotinib in JIA' on April 21.
Brief Summary: This OLE study is designed to evaluate long-term safety, tolerability, and efficacy of filgotinib in patients with polyarticular or systemic juvenile idiopathic arthritis (pJIA-sJIA) who have completed the treatment period/prolonged treatment period of the parent studies and demonstrated clinical benefit defined as control of disease activity through improvement in signs and symptoms as per Investigator judgement.
Study Start Date: April 20
Study Type: INTERVENTIONAL
Condition:
Juvenile Idiopathic Arthritis (JIA)
Intervention:
DRUG: Filgotinib
Investigational prod...